Human FGFR1 Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB658
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Applications for Human FGFR1 Antibody
Western Blot
Sample: Recombinant Human FGF R1 alpha (IIIb) Fc Chimera (Catalog # 655-FR)
Recombinant Human FGF R1 alpha (IIIc) Fc Chimera (Catalog # 658-FR)
Recombinant Human FGF R1 beta (IIIb) Fc Chimera (Catalog # 765-FR)
Recombinant Human FGF R1 beta (IIIc) Fc Chimera (Catalog # 661-FR)
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: FGFR1
FGF activity is mediated by a family of type I transmembrane tyrosine kinases, which undergo dimerization and autophosphorylation after ligand binding. Five distinct genes encode closely related FGF receptors, FGFR1 through 5. FGFRs contain three Ig-like domains and a stretch of acidic residues between the first and second Ig-like domains. FGFR1, 2, 3, and -4 have a cytoplasmic split tyrosine-kinase domain, but FGFR5 does not. Multiple forms of FGFR1, 2, and 3 are generated by alternative splicing.
Long Name
Alternate Names
Gene Symbol
Additional FGFR1 Products
Product Documents for Human FGFR1 Antibody
Product Specific Notices for Human FGFR1 Antibody
For research use only